3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy
1. Solventum held its 2025 Investor Day outlining growth strategies. 2. Company expects 4%-5% organic sales growth and 10% EPS CAGR by 2028. 3. Adjusted EPS of $1.41 beat expectations; confidence in fiscal guidance maintained. 4. Thermo Fisher acquiring Solventum's $4.1 billion purification business strengthens focus. 5. Stock price down 1.57% at $73.81 following the event.